Your browser doesn't support javascript.
loading
Improvements in brain and behavior following eradication of hepatitis C.
Kuhn, Taylor; Sayegh, Philip; Jones, Jacob D; Smith, Jason; Sarma, Manoj K; Ragin, A; Singer, Elyse J; Albert Thomas, M; Thames, April D; Castellon, Steven A; Hinkin, Charles H.
Afiliação
  • Kuhn T; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (UCLA), 760 Westwood Plaza, #C8-749, Los Angeles, CA, 90095, USA. tkuhn@mednet.ucla.edu.
  • Sayegh P; Psychology Service, Veterans Administration (VA) Greater Los Angeles Healthcare System, 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA. tkuhn@mednet.ucla.edu.
  • Jones JD; Department of Psychology, UCLA, 2191 Franz Hall, Box 951563, Los Angeles, CA, 90095, USA.
  • Smith J; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (UCLA), 760 Westwood Plaza, #C8-749, Los Angeles, CA, 90095, USA.
  • Sarma MK; Psychology Service, Veterans Administration (VA) Greater Los Angeles Healthcare System, 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA.
  • Ragin A; Psychology Service, Veterans Administration (VA) Greater Los Angeles Healthcare System, 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA.
  • Singer EJ; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (UCLA), 760 Westwood Plaza, #C8-749, Los Angeles, CA, 90095, USA.
  • Albert Thomas M; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (UCLA), 760 Westwood Plaza, #C8-749, Los Angeles, CA, 90095, USA.
  • Thames AD; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Castellon SA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (UCLA), 760 Westwood Plaza, #C8-749, Los Angeles, CA, 90095, USA.
  • Hinkin CH; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (UCLA), 760 Westwood Plaza, #C8-749, Los Angeles, CA, 90095, USA.
J Neurovirol ; 23(4): 593-602, 2017 08.
Article em En | MEDLINE | ID: mdl-28560632
ABSTRACT
Despite recent advances in treatment, hepatitis C remains a significant public health problem. The hepatitis C virus (HCV) is known to infiltrate the brain, yet findings from studies on associated neurocognitive and neuropathological changes are mixed. Furthermore, it remains unclear if HCV eradication improves HCV-associated neurological compromise. This study examined the longitudinal relationship between neurocognitive and neurophysiologic markers among healthy HCV- controls and HCV+ adults following successful HCV eradication. We hypothesized that neurocognitive outcomes following treatment would be related to both improved cognition and white matter integrity. Participants included 57 HCV+ participants who successfully cleared the virus at the end of treatment (sustained virologic responders [SVRs]) and 22 HCV- controls. Participants underwent neuropsychological testing and, for a nested subset of participants, neuroimaging (diffusion tensor imaging) at baseline and 12 weeks following completion of HCV therapy. Contrary to expectation, group-level longitudinal analyses did not reveal significant improvement in neurocognitive performance in the SVRs compared to the control group. However, a subgroup of SVRs demonstrated a significant improvement in cognition relative to controls, which was related to improved white matter integrity. Indeed, neuroimaging data revealed beneficial effects associated with clearing the virus, particularly in the posterior corona radiata and the superior longitudinal fasciculus. Findings suggest that a subgroup of HCV+ patients experienced improvements in cognitive functioning following eradication of HCV, which appears related to positive changes in white matter integrity. Future research should examine whether any additional improvements in neurocognition and white matter integrity among SVRs occur with longer follow-up periods.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Hepacivirus / Hepatite C Crônica / Função Executiva / Substância Branca Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurovirol Assunto da revista: NEUROLOGIA / VIROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Hepacivirus / Hepatite C Crônica / Função Executiva / Substância Branca Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurovirol Assunto da revista: NEUROLOGIA / VIROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos